Surmodics, Inc.
Surmodics, Inc. (SRDX) Revenue
Annual & quarterly revenue history · segment & region breakdown
SRDX · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsSurmodics, Inc. trailing twelve-month (TTM) revenue is $0.12B, a decrease of 4.91% year-over-year from $0.13B in FY2024.
Revenue trend
2024 – 2005 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2024-09-30 | $0.13B | -$0.01B | -4.91% |
| 2023-09-30 | $0.13B | +$0.03B | +32.65% |
| 2022-09-30 | $0.10B | -$0.01B | -4.93% |
| 2021-09-30 | $0.11B | +$0.01B | +10.83% |
| 2020-09-30 | $0.09B | -$0.01B | -5.21% |
| 2019-09-30 | $0.10B | +$0.02B | +23.04% |
| 2018-09-30 | $0.08B | +$0.01B | +11.25% |
| 2017-09-30 | $0.07B | +$0.00B | +2.45% |
| 2016-09-30 | $0.07B | +$0.01B | +15.30% |
| 2015-09-30 | $0.06B | +$0.00B | +7.76% |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Surmodics, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Surmodics, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Surmodics, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
SRDX revenue · 4 questionsSRDX's trailing twelve-month (TTM) revenue is $0.12B. That is a decrease of 4.91% year-over-year from $0.13B in FY2024.
▸ Source: FMP · Surmodics, Inc. SEC filings · GAAP · Surmodics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026